In the BioHarmony Drug Report Database

"Preview" Icon

Treprostinil diolamine

Orenitram, Trepulmix (treprostinil diolamine) is a small molecule pharmaceutical. Treprostinil diolamine was first approved as Orenitram on 2013-12-20. It is used to treat pulmonary hypertension in the USA. It has been approved in Europe to treat pulmonary hypertension. Orenitram’s patents are valid until 2031-08-11 (FDA).

 

Trade Name

 

Trepulmix
 

Common Name

 

treprostinil diolamine
 

ChEMBL ID

 

CHEMBL2107815
 

Indication

 

pulmonary hypertension
 

Drug Class

 

Prostaglandins

Image (chem structure or protein)

Treprostinil diolamine structure rendering